EVALUATION OF HEALTH RELATED QUALITY OF LIFE IN DOGS TREATED WITH CHEMOTHERAPY FOR LYMPHOMA
Journal
Acta Veterinaria-Beograd
Date Issued
2023-06-15
Author(s)
Atanaskova Petrov, Elena
Kjosevski, Miroslav
Celeska Irena,
DOI
10.2478/acve-2023-0017
Abstract
Lymphoma is the most common hematopoietic tumor in dogs. The standard diagnostic
approach and staging includes detailed clinical history, physical examination and
extended laboratory workup including lymph node cytology. Multidrug chemotherapy
is the main treatment of the disease. Often, owners are concerned about the side
effects of the treatment and the quality of life of their dog during chemotherapy.
The aim of this study was to analyze the health related wellbeing of the patients with
lymphoma previous, during and at the end of the chemotherapy. Five patients with
multicentric lymphoma were monitored in three phases (beginning, middle and end
of chemotherapy). The monitoring included clinical examination, laboratory analyses
and a questionnaire for the owner. Results revealed significant improvement (p< 0.1)
of the basic red blood cells parameters (RBC, PCV and Hb), platelets (PLT) as well as
liver enzymes (ALT, AST) and protein status (total protein and globulin). Regarding the
life quality assessed by the owners, dogs’ appetite, general health compared to each visit
and the current quality of life were significantly improved (p<0.1) and all of the owners
were satisfied with the decision for chemotherapy.
approach and staging includes detailed clinical history, physical examination and
extended laboratory workup including lymph node cytology. Multidrug chemotherapy
is the main treatment of the disease. Often, owners are concerned about the side
effects of the treatment and the quality of life of their dog during chemotherapy.
The aim of this study was to analyze the health related wellbeing of the patients with
lymphoma previous, during and at the end of the chemotherapy. Five patients with
multicentric lymphoma were monitored in three phases (beginning, middle and end
of chemotherapy). The monitoring included clinical examination, laboratory analyses
and a questionnaire for the owner. Results revealed significant improvement (p< 0.1)
of the basic red blood cells parameters (RBC, PCV and Hb), platelets (PLT) as well as
liver enzymes (ALT, AST) and protein status (total protein and globulin). Regarding the
life quality assessed by the owners, dogs’ appetite, general health compared to each visit
and the current quality of life were significantly improved (p<0.1) and all of the owners
were satisfied with the decision for chemotherapy.
Subjects
File(s)![Thumbnail Image]()
Loading...
Name
s12917-015-0514-62.pdf
Size
467.71 KB
Format
Adobe PDF
Checksum
(MD5):420068ac9e66f7398cbb835b3057e97c